Entasis Therapeutics Readies $75 Million IPO Plan

Karuna Therapeutics Readies Plan For $70 Million IPO.....»»

Two Philadelphia-area biopharmaceutical companies focused on developing cancer therapies expect to raise a total of nearly $160 million from stock offerings Monday. The majority of the funds are expected to be raised by Prelude Therapeutics (NAS.....»»

The VA Western New York Healthcare System is planning a $20 million expansion that includes moving its laboratory out of the main hospital. The new lab is one piece of a $180 million capital plan over the next four years. The largest investments include.....»»

IPO Update: Sprout Social Readies Plan For $150 Million IPO.....»»

IPO Update: BRP Group Readies $246 Million IPO Plan.....»»

IPO Update: ADC Therapeutics Readies $200 Million IPO.....»»

IPO Update: Endeavor Group Readies Plan For $600 Million IPO.....»»

Mirum Pharma Readies $75 Million IPO Plan.....»»

The RealReal Readies $270 Million IPO Plan.....»»

Akero Therapeutics Readies $75 Million IPO.....»»

IPO Update: Brainsway Readies $30 Million U.S. IPO Plan.....»»

IPO Update: Jumia Readies Plan For $196 Million IPO.....»»

Iterum Therapeutics Readies $80 Million IPO Plans.....»»

Eidos Therapeutics Readies $100 Million U.S. IPO.....»»

Neon Therapeutics Firms Its Plan For $100 Million IPO.....»»

Aquestive Therapeutics Readies $60 Million IPO.....»»

Mesa Air Group Readies Plan For $161 Million IPO.....»»

Rockville-based biotechnology company Remedy Plan Therapeutics took home $5,000 Thursday as the winner of the Maryland Tech Council's inaugural Bio+Tech18 pitch competition. That money will go toward a larger, $13 million round the company is looking .....»»

Eton Pharmaceuticals Readies Plan For $18 Million IPO.....»»

In this week’s Petri Dish we’ll take a look at a new Cambridge company founded by gene-editing experts that emerged with some big funding, as well as Foghorn Therapeutics’ new CFO and the awardees of $2.8 million in women's health funding......»»